Merit Medical Systems, Inc. (MMSI)
NASDAQ: MMSI · Real-Time Price · USD
85.70
-0.10 (-0.11%)
Nov 18, 2025, 9:36 AM EST - Market open
Merit Medical Systems Revenue
Merit Medical Systems had revenue of $384.16M in the quarter ending September 30, 2025, with 13.04% growth. This brings the company's revenue in the last twelve months to $1.48B, up 11.41% year-over-year. In the year 2024, Merit Medical Systems had annual revenue of $1.36B with 7.89% growth.
Revenue (ttm)
$1.48B
Revenue Growth
+11.41%
P/S Ratio
3.42
Revenue / Employee
$199,612
Employees
7,400
Market Cap
5.08B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.36B | 99.15M | 7.89% |
| Dec 31, 2023 | 1.26B | 106.39M | 9.24% |
| Dec 31, 2022 | 1.15B | 76.23M | 7.09% |
| Dec 31, 2021 | 1.07B | 110.88M | 11.50% |
| Dec 31, 2020 | 963.88M | -30.98M | -3.11% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
MMSI News
- 5 days ago - Carillon Eagle Small Cap Growth Fund Q3 2025 Portfolio Update - Seeking Alpha
- 15 days ago - Merit Medical Releases 24-Month Efficacy Results from the Single-Arm Arteriovenous Graft (AVG) Cohort of the WRAPSODY Arteriovenous Access Efficacy (WAVE) Trial - GlobeNewsWire
- 18 days ago - Merit Medical Systems, Inc. (MMSI) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - PENTAX Medical Announces Sale of C2 CryoBalloon™ Product Line to Merit Medical Systems through Asset Purchase Agreement - PRNewsWire
- 6 weeks ago - Merit Medical Systems to Announce Third Quarter 2025 Results on October 30, 2025 - GlobeNewsWire
- 6 weeks ago - Merit Medical Announces SCOUT Milestone: 750,000 Patients Treated with Wire-Free Technology - GlobeNewsWire
- 2 months ago - Merit Medical Embosphere Microspheres Achieve CE Mark for Genicular Artery Embolisation to Treat Knee Osteoarthritis - GlobeNewsWire
- 2 months ago - Merit Medical Has To Rebuild Some Confidence In The Growth Story - Seeking Alpha